Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Hibsago

Pharmaceutical Executive Daily: FDA Approves Hibsago

Published 4 weeks ago
Description
A new ICER and West Health report finds median drug launch prices climbed to $257,000, the FDA approves GSK’s Hibsago as the first functional-cure therapy for chronic hepatitis B, and CSL names Deborah Waterhouse as CEO and managing director.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us